ECTRIMS eLearning

The positive effect of cognitive behavioral therapy for the treatment of fatigue in patients with multiple sclerosis: results of a randomized controlled trial
Author(s): ,
L van den Akker
Affiliations:
VU University Medical Center, Amsterdam
,
H Beckerman
Affiliations:
VU University Medical Center, Amsterdam
,
E.H Collette
Affiliations:
VU University Medical Center, Amsterdam
,
J Twisk
Affiliations:
VU University Medical Center, Amsterdam
,
G Blijenberg
Affiliations:
Radboud University Medical Centre, Nijmegen, The Netherlands
,
H Knoop
Affiliations:
Radboud University Medical Centre, Nijmegen, The Netherlands
,
J Dekker
Affiliations:
VU University Medical Center, Amsterdam
,
V de Groot
Affiliations:
VU University Medical Center, Amsterdam
TREFAMS-ACE Study Group
TREFAMS-ACE Study Group
Affiliations:
ECTRIMS Learn. van den Akker L. 09/16/16; 146631; P791
Lizanne van den Akker
Lizanne van den Akker
Contributions
Abstract

Abstract: P791

Type: Poster

Abstract Category: RIMS - Neuropsychology and fatigue management

Background: MS-related fatigue is a common symptom in Multiple Sclerosis (MS) that restricts societal participation. Literature suggests that Cognitive Behavioral Therapy (CBT) alleviates MS-related fatigue, but evidence is inconclusive. The study objective was to evaluate the effectiveness of CBT to improve MS-related fatigue and participation in patients with MS.

Methods: In a multicenter, assessor-masked, randomized-controlled trial in 3 Dutch healthcare institutions, participants with severe MS-related fatigue were assigned to the CBT or control study group. The CBT study group received twelve individual face-to-face sessions with a certified psychologist; the control study group received 3 individual sessions with an MS-nurse, both for a duration of 16 weeks. Assessments took place at baseline, 8, 16 (i.e. post-intervention), 26 and 52 weeks follow-up. Primary outcomes were the Checklist Individual Strength-fatigue subscale (CIS20r-fatigue) and the Impact on Participation and Autonomy questionnaire (IPA). Data were analyzed with the intention-to-treat principle using Mixed Model Analysis. The Controlled Trials registration number is ISRCTN58583714.

Findings: Between December 2011 and August 2014, 91 patients were randomly assigned to the CBT (n=44) or to the MS-nurse study group (n=47). The between-group analysis showed a positive post-intervention effect for CBT on the CIS20r-fatigue (T16: -6•7 [95%CI -10•7; -2•7] points) that diminished during follow up (T26: -3•5 [95%CI -7•4; 0•5]; T52: 0•5 [95%CI -3•6; 4•4]). No clinically relevant effects were found on societal participation. Post-intervention (T16), 22 out of 39 in the CBT, and 9 out of 37 patients in the control study group showed a clinically-relevant improvement of 8-points or more on the CIS20r-fatigue, leading to a number needed to treat of 3•3 (95%CI 1•9;10•6).

Interpretation: Severe MS-related fatigue can be reduced effectively with CBT. However, effects wear off after cessation of treatment, societal participation does not improve.

Disclosure:

Lizanne E van den Akker: nothing to disclose

Heleen Beckerman: nothing to disclose

Emma H Collette: nothing to disclose

Jos Twisk: nothing to disclose

Gijs Bleijenberg: nothing to disclose

Hans Knoop: nothing to disclose

Joost Dekker: nothing to disclose

Vincent de Groot: nothing to disclose

Abstract: P791

Type: Poster

Abstract Category: RIMS - Neuropsychology and fatigue management

Background: MS-related fatigue is a common symptom in Multiple Sclerosis (MS) that restricts societal participation. Literature suggests that Cognitive Behavioral Therapy (CBT) alleviates MS-related fatigue, but evidence is inconclusive. The study objective was to evaluate the effectiveness of CBT to improve MS-related fatigue and participation in patients with MS.

Methods: In a multicenter, assessor-masked, randomized-controlled trial in 3 Dutch healthcare institutions, participants with severe MS-related fatigue were assigned to the CBT or control study group. The CBT study group received twelve individual face-to-face sessions with a certified psychologist; the control study group received 3 individual sessions with an MS-nurse, both for a duration of 16 weeks. Assessments took place at baseline, 8, 16 (i.e. post-intervention), 26 and 52 weeks follow-up. Primary outcomes were the Checklist Individual Strength-fatigue subscale (CIS20r-fatigue) and the Impact on Participation and Autonomy questionnaire (IPA). Data were analyzed with the intention-to-treat principle using Mixed Model Analysis. The Controlled Trials registration number is ISRCTN58583714.

Findings: Between December 2011 and August 2014, 91 patients were randomly assigned to the CBT (n=44) or to the MS-nurse study group (n=47). The between-group analysis showed a positive post-intervention effect for CBT on the CIS20r-fatigue (T16: -6•7 [95%CI -10•7; -2•7] points) that diminished during follow up (T26: -3•5 [95%CI -7•4; 0•5]; T52: 0•5 [95%CI -3•6; 4•4]). No clinically relevant effects were found on societal participation. Post-intervention (T16), 22 out of 39 in the CBT, and 9 out of 37 patients in the control study group showed a clinically-relevant improvement of 8-points or more on the CIS20r-fatigue, leading to a number needed to treat of 3•3 (95%CI 1•9;10•6).

Interpretation: Severe MS-related fatigue can be reduced effectively with CBT. However, effects wear off after cessation of treatment, societal participation does not improve.

Disclosure:

Lizanne E van den Akker: nothing to disclose

Heleen Beckerman: nothing to disclose

Emma H Collette: nothing to disclose

Jos Twisk: nothing to disclose

Gijs Bleijenberg: nothing to disclose

Hans Knoop: nothing to disclose

Joost Dekker: nothing to disclose

Vincent de Groot: nothing to disclose

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies